141 related articles for article (PubMed ID: 12422526)
1. Toxinogenicity and markers of pathogenicity of Pseudomonas aeruginosa strains isolated from patients with tumor diseases.
Majtán V; Hostacká A; Majtánová L; Trupl J
Folia Microbiol (Praha); 2002; 47(4):445-9. PubMed ID: 12422526
[TBL] [Abstract][Full Text] [Related]
2. Serotyping and virulence factors of Pseudomonas aeruginosa clinical isolates.
Hostacká A; Majtán V
Acta Microbiol Immunol Hung; 1997; 44(2):141-6. PubMed ID: 9330662
[TBL] [Abstract][Full Text] [Related]
3. [Alginate, elastase and alkaline protease production of Pseudomonas aeruginosa strains isolated from various body sites].
Ciragil P; Söyletir G
Mikrobiyol Bul; 2004 Oct; 38(4):341-7. PubMed ID: 15700659
[TBL] [Abstract][Full Text] [Related]
4. Influence of growth media on potential virulence factors of Pseudomonas aeruginosa.
Hostacká A
Cent Eur J Public Health; 2003 Sep; 11(3):129-31. PubMed ID: 14514163
[TBL] [Abstract][Full Text] [Related]
5. Decreased virulence of a strain of Pseudomonas aeruginosa O12 overexpressing a chromosomal type 1 beta-lactamase could be due to reduced expression of cell-to-cell signaling dependent virulence factors.
Ramisse F; van Delden C; Gidenne S; Cavallo J; Hernandez E
FEMS Immunol Med Microbiol; 2000 Jul; 28(3):241-5. PubMed ID: 10865177
[TBL] [Abstract][Full Text] [Related]
6. Suppression of virulence factors of pseudomonas aeruginosa by subinhibitory concentrations of quaternary ammonium salts.
Majtán V; Hostacká A; Mlynarcik D; Devínsky F
Arzneimittelforschung; 1995 Mar; 45(3):327-30. PubMed ID: 7741795
[TBL] [Abstract][Full Text] [Related]
7. Role of alkaline protease and elastase in the adherence of Pseudomonas aeruginosa to WEHI cells.
Trancassini M; Magni A; Ghezzi MC; Nazzari C; Brenciaglia MI; Filadoro F
Microbiologica; 1989 Jul; 12(3):257-61. PubMed ID: 2506409
[TBL] [Abstract][Full Text] [Related]
8. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
[TBL] [Abstract][Full Text] [Related]
9. Extracellular enzymes of fecal strains of Pseudomonas aeruginosa.
Marne C; Vindel A
Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):307-9. PubMed ID: 2839341
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial efficacy of quaternary bisammonium salts and the effect of their sub-MICs on Pseudomonas aeruginosa virulence factors.
Hostacká A; Majtán V; Hybenová D
Folia Microbiol (Praha); 1995; 40(3):283-7. PubMed ID: 8919934
[TBL] [Abstract][Full Text] [Related]
11. Virulence attributes in Brazilian clinical isolates of Pseudomonas aeruginosa.
Silva LV; Galdino AC; Nunes AP; dos Santos KR; Moreira BM; Cacci LC; Sodré CL; Ziccardi M; Branquinha MH; Santos AL
Int J Med Microbiol; 2014 Nov; 304(8):990-1000. PubMed ID: 25127423
[TBL] [Abstract][Full Text] [Related]
12. Effect of pH on production of virulence factors by biofilm cells of Pseudomonas aeruginosa.
Harjai K; Khandwahaa RK; Mittal R; Yadav V; Gupta V; Sharma S
Folia Microbiol (Praha); 2005; 50(2):99-102. PubMed ID: 16110911
[TBL] [Abstract][Full Text] [Related]
13. Subinhibitory concentrations of antibacterial drugs and Pseudomonas aeruginosa virulence factors.
Trancassini M; Giordano A; Magni A; Cipriani P
New Microbiol; 1993 Jul; 16(3):275-9. PubMed ID: 8366823
[TBL] [Abstract][Full Text] [Related]
14. Subinhibitory concentrations of phenyl lactic acid interfere with the expression of virulence factors in Staphylococcus aureus and Pseudomonas aeruginosa clinical strains.
Chifiriuc MC; Diţu LM; Banu O; Bleotu C; Drăcea O; Bucur M; Larion C; Israil AM; Lazăr V
Roum Arch Microbiol Immunol; 2009; 68(1):27-33. PubMed ID: 19507624
[TBL] [Abstract][Full Text] [Related]
15. Virulence determinants in Pseudomonas aeruginosa strains from urinary tract infections.
Visca P; Chiarini F; Mansi A; Vetriani C; Serino L; Orsi N
Epidemiol Infect; 1992 Apr; 108(2):323-36. PubMed ID: 1582473
[TBL] [Abstract][Full Text] [Related]
16. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
[TBL] [Abstract][Full Text] [Related]
17. Potential virulence-associated properties of Plesiomonas shigelloides strains.
Ciznár I; Hostacka A; Gonzalez-Rey C; Krovacek K
Folia Microbiol (Praha); 2004; 49(5):543-8. PubMed ID: 15702543
[TBL] [Abstract][Full Text] [Related]
18. Alginate, the slime exopolysaccharide of Pseudomonas aeruginosa, binds human leukocyte elastase, retards inhibition by alpha 1-proteinase inhibitor, and accelerates inhibition by secretory leukoprotease inhibitor.
Ying QL; Kemme M; Simon SR
Am J Respir Cell Mol Biol; 1996 Aug; 15(2):283-91. PubMed ID: 8703486
[TBL] [Abstract][Full Text] [Related]
19. Alginate production by the mucoid Pseudomonas aeruginosa associated with cystic fibrosis.
Gill JF; Deretic V; Chakrabarty AM
Microbiol Sci; 1987 Oct; 4(10):296-9. PubMed ID: 3155272
[TBL] [Abstract][Full Text] [Related]
20. Typing of Pseudomonas aeruginosa strains in Turkish cystic fibrosis patients.
Yagci A; Ciragil P; Over U; Sener B; Erturan Z; Soyletir G
New Microbiol; 2003 Jan; 26(1):109-14. PubMed ID: 12578318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
